Nasal Decolonisation of MRSA
Faculty of Natural Sciences, Imperial College London, South Kensington, London SW7 2AZ, UK
Antibiotics 2019, 8(1), 14; https://doi.org/10.3390/antibiotics8010014
Submission received: 14 January 2019
/
Revised: 28 January 2019
/
Accepted: 2 February 2019
/
Published: 4 February 2019
Abstract
The recent demonstration for the first time of urinary monic acid A as a clinical urinary biomarker of exposure to intra-nasal mupirocin during medication for methicillin-resistant Staphylococcus aureus (MRSA) offers a way of verifying adherence to the regimen. However, absence of the biomarker in some patients needs explanation, to ensure that efficient decolonisation has not been compromised by confounding circumstances, and that additional resistance to mupirocin has not unwittingly been encouraged.
Keywords:
Mupirocin; urinary biomarker; pseudomonic acid A; monic acid A; MRSA
Share and Cite
MDPI and ACS Style
Mantle, P. Nasal Decolonisation of MRSA. Antibiotics 2019, 8, 14. https://doi.org/10.3390/antibiotics8010014
AMA Style
Mantle P. Nasal Decolonisation of MRSA. Antibiotics. 2019; 8(1):14. https://doi.org/10.3390/antibiotics8010014
Chicago/Turabian StyleMantle, Peter. 2019. "Nasal Decolonisation of MRSA" Antibiotics 8, no. 1: 14. https://doi.org/10.3390/antibiotics8010014
APA StyleMantle, P. (2019). Nasal Decolonisation of MRSA. Antibiotics, 8(1), 14. https://doi.org/10.3390/antibiotics8010014
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
